Cancer Society Herceptin Statement
3 April 2006
Cancer Society Herceptin Statement
In light of the recent media coverage over the access of women with early stage breast cancer to the drug Hercpetin, the Cancer Society of New Zealand has released a statement on its position.
Chief Executive Neil Chave says, “The Cancer Society supports the view that all New Zealanders should have access to the very best possible treatment available for their condition.
“The Cancer Society is pleased to acknowledge the progress of the drug approval process for Herceptin in New Zealand.”
The Society recognises there are issues in relation to the funding of the drug but nevertheless reiterates its belief that everyone in this country has the right to the treatment which gives them the best health outcome achievable.
ENDS
New Zealand Olympic Committee: Motherhood In Focus For Wāhine Toa Graduates Ahead Of Mother's Day
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future